Publications by authors named "Elisabeth Minder"

Claim this Profile
L
Long-term iron supplementation in four patients with X-linked erythropoietic protoporphyria: associations with serum proteins and erythrocyte protoporphyrin levels-a single-centre retrospective study.
Anna-Elisabeth Minder, Francesca Granata, Franziska van Breemen, Xiaoye Schneider-Yin, Elisabeth I Minder

Front Mol Biosci· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Erythropoietic protoporphyrias: Pathogenesis, diagnosis and management.
Anna-Elisabeth Minder, Louisa G Kluijver, Jasmin Barman-Aksözen, Elisabeth I Minder, Janneke G Langendonk

Liver Int· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
First Report of a Low-Frequency Mosaic Mutation in the Hydroxymethylbilane Synthase Gene Causing Acute Intermittent Porphyria.
Adrian Belosevic, Anna-Elisabeth Minder, Morgan Gueuning, Franziska van Breemen, Gian Andri Thun, Elisabeth I Minder

Life (Basel)· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Severe Abdominal Pain After Bariatric Surgery: Think Twice-Think Porphyria!
Jochen A Vielhaber, Jasmin Barman-Aksözen, Elisabeth I Minder, Xiaoye Schneider-Yin, Henryk Zulewski, Anna-Elisabeth Minder

Obes Surg· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Afamelanotide Is Associated with Dose-Dependent Protective Effect from Liver Damage Related to Erythropoietic Protoporphyria.
Anna-Elisabeth Minder, Xiaoye Schneider-Yin, Henryk Zulewski, Christoph E Minder, Elisabeth I Minder

Life (Basel)· April 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Case Report: Variegate porphyria disclosed by post-gastric bypass complications and causing predominant painful sensorimotor axonal peripheral neuropathy.
Edwige Collaud, Luis Wittwer, Anna-Elisabeth Minder, Jean-Marie Annoni, Elisabeth I Minder

Front Genet· October 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Beyond pigmentation: signs of liver protection during afamelanotide treatment in Swiss patients with erythropoietic protoporphyria, an observational study.
Anna-Elisabeth Minder, Jasmin Barman-Aksoezen, Mathias Schmid, Elisabeth I Minder, Henryk Zulewski, Christoph E Minder

Ther Adv Rare Dis· December 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Repurposing of glycine transport inhibitors for the treatment of erythropoietic protoporphyria.
François Halloy, Pavithra S Iyer, Alice Ghidini, Veronika Lysenko, Jasmin Barman-Aksözen, Elisabeth I Minder, Anna-Elisabeth Minder

Cell Chem Biol· August 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase 3 Trial of RNAi Therapeutic Givosiran for Acute Intermittent Porphyria.
Manisha Balwani, Eliane Sardh, Paolo Ventura, Paula Aguilera Peiró, David C Rees, Elisabeth Minder

N Engl J Med· June 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
EXPLORE: A Prospective, Multinational, Natural History Study of Patients with Acute Hepatic Porphyria with Recurrent Attacks.
Laurent Gouya, Paolo Ventura, Manisha Balwani, D Montgomery Bissell, David C Rees, Elisabeth Minder

Hepatology· May 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Delivery of oligonucleotides to bone marrow to modulate ferrochelatase splicing in a mouse model of erythropoietic protoporphyria.
François Halloy, Pavithra S Iyer, Paulina Ćwiek, Alice Ghidini, Jasmin Barman-Aksözen, Elisabeth I Minder

Nucleic Acids Res· May 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Delta-aminolevulinic acid synthase 2 expression in combination with iron as modifiers of disease severity in erythropoietic protoporphyria.
Jasmin Barman-Aksözen, Francois Halloy, Pavithra S Iyer, Daniel Schümperli, Anna Elisabeth Minder, Elisabeth I Minder

Mol Genet Metab· November 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A next-generation-sequencing panel for mutational analysis of dominant acute hepatic porphyrias.
Jasmin Barman-Aksözen, Lukas Suter, Franziska Wegmann, Janine Meienberg, Anna Elisabeth Minder, Elisabeth I Minder

Scand J Clin Lab Invest· September 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Porphyria - when to think about how to clarify and treat?].
Anna E Minder, Jasmin Barman-Aksözen, Henryk Zulewski, Xiaoye Schneider-Yin, Elisabeth I Minder

Ther Umsch· November 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Not Available].
Jon-Duri Senn, Lars C Huber, Jasmin Barman-Aksözen, Elisabeth Minder

Praxis (Bern 1994)· February 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[CME: Acute Intermittent Porphyria: When to Think of It? What Must be Checked? How to Treat?].
Jon-Duri Senn, Lars C Huber, Jasmin Barman-Aksözen, Elisabeth Minder

Praxis (Bern 1994)· January 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmacokinetics and Pharmacodynamics of Afamelanotide and its Clinical Use in Treating Dermatologic Disorders.
Elisabeth I Minder, Jasmin Barman-Aksoezen, Xiaoye Schneider-Yin

Clin Pharmacokinet· August 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Disturbed iron metabolism in erythropoietic protoporphyria and association of GDF15 and gender with disease severity.
Jasmin Barman-Aksoezen, Domenico Girelli, Caterina Aurizi, Xiaoye Schneider-Yin, Natascia Campostrini, Elisabeth I Minder

J Inherit Metab Dis· May 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Modeling the ferrochelatase c.315-48C modifier mutation for erythropoietic protoporphyria (EPP) in mice.
Jasmin Barman-Aksözen, Paulina C Wiek, Vijay B Bansode, Frank Koentgen, Judith Trüb, Elisabeth I Minder

Dis Model Mech· March 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Reference intervals for 24 laboratory parameters determined in 24-hour urine collections.
Raffaele Curcio, Helen Stettler, Paolo M Suter, Jasmin Barman Aksözen, Lanja Saleh, Elisabeth Minder

Clin Chem Lab Med· January 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluation of the immunogenicity of the synthetic α-melanocyte-stimulating hormone (α-MSH) analogue afamelanotide ([Nle4-D-Phe7]-α-MSH, Scenesse®) in erythropoietic protoporphyria patients by ELISA detecting both anti-afamelanotide and anti-α-MSH antibodies.
Stephan Lengweiler, Saskia Kreim, Jasmin Barman-Aksözen, Marcus Maurer, Elisabeth I Minder

Skin Pharmacol Physiol· November 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Iron and erythropoietic porphyrias.
Elisabeth I Minder, Jasmin Barman-Aksözen

Blood· July 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Biallelic inactivation of protoporphyrinogen oxidase and hydroxymethylbilane synthase is associated with liver cancer in acute porphyrias.
Xiaoye Schneider-Yin, Anne-Moon van Tuyll van Serooskerken, Marko Siegesmund, Philip Went, Jasmin Barman-Aksözen, Elisabeth I Minder

J Hepatol· March 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
In ferrochelatase-deficient protoporphyria patients, ALAS2 expression is enhanced and erythrocytic protoporphyrin concentration correlates with iron availability.
Jasmin Barman-Aksözen, Elisabeth I Minder, Carina Schubiger, Gianfranco Biolcati, Xiaoye Schneider-Yin

Blood Cells Mol Dis· January 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Afamelanotide (CUV1647) in dermal phototoxicity of erythropoietic protoporphyria.
Elisabeth I Minder, Xiaoye Schneider-Yin

Expert Rev Clin Pharmacol· January 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis